.cancerresearch

The Big picture…

The Big Picture

Australian Cancer Research Foundation

.CANCERRESEARCH is a collaborative initiative facilitated by the Australian Cancer Research Foundation. Its focus is to bring together news, information, and leading opinion on cancer treatment, prevention, diagnosis and cure. We want you to be a part of the .CANCERRESEARCH community...

Please click here to learn more.

Home.

Cancer
Research

HOME.CANCERRESEARCH

Explore our home site for an idea of what .CANCERRESEARCH has to offer.

> Information on different types of cancer
> Cancer research endeavours of the past and near future
> Ways you can get involved

Visit our home site home.cancerresearch

 

Cluster of cancer cells spreads more efficiently

 
ACRF
ACRF
October 7, 2015
This post was originally published on theconversation.com.

Nine out of ten cancer patients die because cancer cells enter the blood circulation, spread and form tumours at distant organs. In circulation, cells can move individually or in a cluster. It is believed that cells moving individually pose the highest risk of forming tumours and are the primary “villains”.

A study we published in the Journal of Royal Society Interface shows that this may not be true. Instead, cells that move in a cluster might be the primary “villains”, hence asking for new ways of fighting the spread of cancer.

Cells in most primary tumours are usually immovable and tied to each other. But some of them lose their adhesion and start invading their neighbouring tissue, gaining access to blood vessels and entering circulation.

All in it together

A few cells that move individually also attain special properties that allow them to adapt to a new environment and seed a new tumour there. These traits are similar to the traits of stem cells – that’s why these cells are called as ‘Cancer Stem Cells’. They are resistant to all current cancer therapies, and can start a new tumour in any organ.

Brain metastasis.
Nephron, CC BY

We found that cells moving collectively are more likely to become Cancer Stem Cells and thus are the primary “villains” of metastasis – the spread of cancer to different organs. This occurs because the mechanism by which cancer cells decide to move collectively also triggers the mechanism which converts it into stem cells, but if cancer cells decide to move individually, their mechanism to gain properties of stem cells can be shut down. Therefore, cells moving in a cluster in the bloodstream pose a much higher risk of starting a new tumour at a distant organ than those moving individually.

This finding means that to fight metastasis, we need new drugs that can breakdown clumps of cancer cells, not lone agents.

Team work has benefits

Posing a higher risk of metastasis is not the only advantage of moving collectively for a cancer. Cells moving individually in circulation die more frequently than those moving as a cluster, thus more clusters than individual cells reach the metastatic site.

Also, when these cells grow into a new tumour, they need to settle down in their new place quickly. This is because cells can’t multi-task efficiently – they can either divide or move. After reaching the new site, they want to start dividing, and doing that is much easier for cells moving collectively. They adhere to each other, rather than find something settle down.

Leaving their primary home, surviving in the harsh conditions in the human bloodstream, and then settling down and seeding a new home (a secondary tumor) at a distant organ, is not easy. And cancer seems to prepare its “soldiers” well for this by instructing them to move in a group or cluster.

Collective migration of cells is a well-planned strategy adopted by cancer for its utmost benefit – cells moving collectively die less in circulation, find it easy to settle down in a new organ, and most importantly, are more drug-resistant and potent to start a new tumour.

Mohit Kumar Jolly does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond the academic appointment of Graduate student in Cancer Systems Biology, Rice University.

Subscribe to our newsletter